Maastricht University Medical Center: Breast Neoplasms trials
The registry lists 15 Breast Neoplasms studies with Maastricht University Medical Center as lead sponsor. 6 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 1No phase 12(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Autologous Fat Grafting for Total Breast Reconstruction in Irradiated Breast Cancer PatientsRecruitingNCT07641985Not applicable
- The Robot-LVA Study: Robot-assisted Microsurgical Lymphaticovenous Anastomosis in Breast Cancer-related LymphedemaRecruitingNCT06532955Not applicable
- 18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Breast Cancer.RecruitingNCT06335069Phase 2
- Feasibility of a Preoperative, Multimodal Lifestyle Intervention in Patients with BreastcancerRecruitingNCT06266312Not applicable
- Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast CancerRecruitingNCT04486495
- PET-MRI for Axillary Staging in Node Negative Breast Cancer PatientsRecruitingNCT03374826Not applicable
- Reduced Contrast Administration in Contrast-enhanced Spectral Mammography (CESM)TerminatedNCT03008031Not applicable
- Omitting Sentinel Node Procedure in Breast Cancer Patients Undergoing Breast Conserving TherapyCompletedNCT02271828Not applicable
- Omitting Completion Axillary Treatment in Sentinel Node Positive Breast Cancer Patients Undergoing a MastectomyTerminatedNCT02112682Not applicable
- Real World Efficiency of Trastuzumab in Early Breast CancerCompletedNCT01894711
- Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast CancerCompletedNCT01695226Phase 2
- Nodal Staging in Breast Cancer With MRLTerminatedNCT01609920Not applicable
- Gadofosveset for Axillary Staging in Breast Cancer PatientsCompletedNCT01437865Not applicable
- Prediction of Pain After Breast Cancer Surgery With EEGTerminatedNCT01392248
- Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast CancerCompletedNCT00301457Phase 3